Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANIP
#1862
ANI Pharmaceuticals, Inc.
73.900
0
-2.95%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-2.95%
Monthly Change
-7.56%
6 month change
-21.91%
Year Change
-21.91%
Previous Close
76.145
0
Open
73.900
0
Bid
Ask
Low
73.900
0
High
73.900
0
Volume
73
Markets
US Stock Market
Healthcare
ANIP
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View
ANI Pharma T4 2025: cambio hacia enfermedades raras impulsa crecimiento de ingresos del 44%
ANI Pharma Q4 2025 slides: rare disease shift drives 44% revenue growth
ANI Pharma superaron 0.36$ las previsiones de BPA en el cuarto trimestre del año
ANI Pharma supera por 0,36$ las previsiones de BPA en el cuarto trimestre del año
ANI Pharma earnings beat by $0.36, revenue topped estimates
ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% - ANI Pharmaceuticals (NASDAQ:ANIP)
Brightspring Health Services, BASF, Swiss Re and more set to report Friday
ANI Pharmaceuticals presentará resultados con Cortrophin impulsando el cambio